vs
Side-by-side financial comparison of ACNB CORP (ACNB) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $47.2M, roughly 1.6× ACNB CORP). On growth, ACNB CORP posted the faster year-over-year revenue change (42.2% vs 27.7%). ACNB CORP produced more free cash flow last quarter ($52.6M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 22.1%).
ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
ACNB vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $75.5M |
| Net Profit | $10.8M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 27.9% | 22.7% |
| Net Margin | 22.9% | — |
| Revenue YoY | 42.2% | 27.7% |
| Net Profit YoY | 63.8% | — |
| EPS (diluted) | $1.10 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.2M | $75.5M | ||
| Q3 25 | $50.9M | $54.5M | ||
| Q2 25 | $50.3M | $52.4M | ||
| Q1 25 | $43.5M | $46.0M | ||
| Q4 24 | $33.2M | $59.1M | ||
| Q3 24 | $34.1M | $80.5M | ||
| Q2 24 | $33.3M | $47.1M | ||
| Q1 24 | $31.6M | $43.8M |
| Q4 25 | $10.8M | — | ||
| Q3 25 | $14.9M | $8.8M | ||
| Q2 25 | $11.6M | $5.9M | ||
| Q1 25 | $-272.0K | $3.0M | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $7.2M | $20.3M | ||
| Q2 24 | $11.3M | $-4.5M | ||
| Q1 24 | $6.8M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 27.9% | 22.7% | ||
| Q3 25 | 37.2% | 17.6% | ||
| Q2 25 | 29.7% | 12.7% | ||
| Q1 25 | -1.3% | 8.7% | ||
| Q4 24 | 24.8% | 22.6% | ||
| Q3 24 | 27.6% | 27.4% | ||
| Q2 24 | 42.8% | -4.6% | ||
| Q1 24 | 26.9% | -5.3% |
| Q4 25 | 22.9% | — | ||
| Q3 25 | 29.2% | 16.2% | ||
| Q2 25 | 23.2% | 11.2% | ||
| Q1 25 | -0.6% | 6.5% | ||
| Q4 24 | 19.9% | — | ||
| Q3 24 | 21.1% | 25.2% | ||
| Q2 24 | 33.9% | -9.6% | ||
| Q1 24 | 21.4% | -11.0% |
| Q4 25 | $1.10 | $0.26 | ||
| Q3 25 | $1.42 | $0.17 | ||
| Q2 25 | $1.11 | $0.12 | ||
| Q1 25 | $-0.03 | $0.06 | ||
| Q4 24 | $0.77 | $0.40 | ||
| Q3 24 | $0.84 | $0.41 | ||
| Q2 24 | $1.32 | $-0.09 | ||
| Q1 24 | $0.80 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $97.5M |
| Total DebtLower is stronger | $255.4M | $22.7M |
| Stockholders' EquityBook value | $420.0M | $130.3M |
| Total Assets | $3.2B | $216.3M |
| Debt / EquityLower = less leverage | 0.61× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | $97.5M | ||
| Q3 25 | $102.1M | $94.4M | ||
| Q2 25 | $103.1M | $96.0M | ||
| Q1 25 | $123.6M | $93.2M | ||
| Q4 24 | $47.3M | $101.0M | ||
| Q3 24 | $58.1M | $96.7M | ||
| Q2 24 | $86.3M | $96.8M | ||
| Q1 24 | $53.1M | $107.2M |
| Q4 25 | $255.4M | $22.7M | ||
| Q3 25 | $255.4M | $34.0M | ||
| Q2 25 | $255.4M | $45.3M | ||
| Q1 25 | $255.3M | $56.7M | ||
| Q4 24 | $255.3M | $68.0M | ||
| Q3 24 | $255.3M | $79.3M | ||
| Q2 24 | $255.3M | $90.7M | ||
| Q1 24 | $255.3M | $102.0M |
| Q4 25 | $420.0M | $130.3M | ||
| Q3 25 | $408.6M | $115.3M | ||
| Q2 25 | $395.2M | $104.7M | ||
| Q1 25 | $386.9M | $97.1M | ||
| Q4 24 | $303.3M | $92.1M | ||
| Q3 24 | $306.8M | $71.1M | ||
| Q2 24 | $289.3M | $48.5M | ||
| Q1 24 | $279.9M | $51.0M |
| Q4 25 | $3.2B | $216.3M | ||
| Q3 25 | $3.3B | $202.9M | ||
| Q2 25 | $3.3B | $194.9M | ||
| Q1 25 | $3.3B | $196.2M | ||
| Q4 24 | $2.4B | $213.3M | ||
| Q3 24 | $2.4B | $220.7M | ||
| Q2 24 | $2.5B | $205.0M | ||
| Q1 24 | $2.4B | $214.1M |
| Q4 25 | 0.61× | 0.17× | ||
| Q3 25 | 0.62× | 0.30× | ||
| Q2 25 | 0.65× | 0.43× | ||
| Q1 25 | 0.66× | 0.58× | ||
| Q4 24 | 0.84× | 0.74× | ||
| Q3 24 | 0.83× | 1.12× | ||
| Q2 24 | 0.88× | 1.87× | ||
| Q1 24 | 0.91× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.6M | $14.4M |
| Free Cash FlowOCF − Capex | $52.6M | $14.4M |
| FCF MarginFCF / Revenue | 111.4% | 19.1% |
| Capex IntensityCapex / Revenue | 2.3% | 0.0% |
| Cash ConversionOCF / Net Profit | 4.96× | — |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.6M | $14.4M | ||
| Q3 25 | $23.2M | $9.7M | ||
| Q2 25 | $17.8M | $14.1M | ||
| Q1 25 | $-71.0K | $3.6M | ||
| Q4 24 | $39.8M | $15.6M | ||
| Q3 24 | $13.6M | $11.0M | ||
| Q2 24 | $9.7M | $1.0M | ||
| Q1 24 | $10.8M | $11.2M |
| Q4 25 | $52.6M | $14.4M | ||
| Q3 25 | $22.8M | $9.7M | ||
| Q2 25 | $17.6M | $14.1M | ||
| Q1 25 | $-730.0K | $3.6M | ||
| Q4 24 | $38.8M | $15.6M | ||
| Q3 24 | $13.3M | $11.0M | ||
| Q2 24 | $9.4M | $1.0M | ||
| Q1 24 | $10.7M | — |
| Q4 25 | 111.4% | 19.1% | ||
| Q3 25 | 44.7% | 17.7% | ||
| Q2 25 | 35.0% | 26.8% | ||
| Q1 25 | -1.7% | 7.7% | ||
| Q4 24 | 117.0% | 26.4% | ||
| Q3 24 | 39.1% | 13.7% | ||
| Q2 24 | 28.3% | 2.1% | ||
| Q1 24 | 33.9% | — |
| Q4 25 | 2.3% | 0.0% | ||
| Q3 25 | 0.8% | 0.0% | ||
| Q2 25 | 0.4% | 0.0% | ||
| Q1 25 | 1.5% | 0.1% | ||
| Q4 24 | 2.9% | 0.0% | ||
| Q3 24 | 0.7% | 0.0% | ||
| Q2 24 | 0.9% | 0.0% | ||
| Q1 24 | 0.2% | 0.0% |
| Q4 25 | 4.96× | — | ||
| Q3 25 | 1.56× | 1.10× | ||
| Q2 25 | 1.52× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 6.03× | — | ||
| Q3 24 | 1.88× | 0.54× | ||
| Q2 24 | 0.86× | — | ||
| Q1 24 | 1.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
